What We Do

Our main research focus is to improve patient outcomes by gaining deeper understanding of lymphoma biology and disease progression which can be translated into clinical applications. Our ultimate goal is to improve patient outcomes through enhanced precision medicine, which can be designed using advanced genomic tools.

News & Events

seed2STEM expands to BC Cancer to improve access to STEM for Indigenous youth

The seed2STEM Summer Research Program for Indigenous Youth increases Indigenous representation in science, technology, engineering and mathematics (STEM) by offering paid, six-week research studentships for Indigenous high school and university students across BC. Developed by ICORD, the program expanded this past summer to BC Cancer in partnership with the Gynecologic Cancer Initiative.

Building a new chapter

Dr. Christian Steidl receives AstraZeneca and Leukemia & Lymphoma Society Grant

Dr. Christian Steidl, senior scientist and Executive Director, Research at BC Cancer, is the recipient of a 2025 Operating Grant in Blood Cancer, co-funded by AstraZeneca Canada and the Leukemia & Lymphoma Society of Canada.

The research is dedicated to developing innovative tools for precise and efficient gene editing in B-cell lymphomas. By targeting the underlying genetic causes of cancer, this work paves the way for novel treatment strategies and opens new possibilities for patients living with B-cell lymphoma.

Research Labs & Principal Investigators

Recent Publications

Back to top